Characterization of Citrobacter sp. line 328 as a source of Vi for a Vi-CRM197 glycoconjugate vaccine against Salmonella Typhi

Characterization of Citrobacter sp. line 328 as a source of Vi for a Vi-CRM197 glycoconjugate vaccine against Salmonella Typhi

Introduction: Salmonella enterica serovar Typhi is the causative agent of typhoid fever with over 22 million cases and over 200,000 deaths reported annually. A vaccine is much needed for use in young children and the Novartis Vaccines Institute for Global Health (NVGH) is developing a conjugate v...

Full description

Saved in:
Bibliographic Details
Main Authors: Simona Rondini, Francesca Micoli, Luisa Lanzilao, Ivan Pisoni, Vito Di Cioccio, Allan J Saul, Laura B Martin
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2012-11-01
Series:Journal of Infection in Developing Countries
Subjects:
S. Typhi
Vi
Citrobacter
conjugate vaccine
Vi-CRM197
Online Access:https://jidc.org/index.php/journal/article/view/2495
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jidc.org/index.php/journal/article/view/2495

Similar Items